Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NBTY buys nutritional bars provider in US
Balance Bar’s nutritional bars, which are available in four product lines including Original, Gold, Bare and Minis, offer good taste and balanced nutrition, according to NBTY. In addition,
Balance Bar’s nutritional bars, which are available in four product lines including Original, Gold, Bare and Minis, offer good taste and balanced nutrition, according to NBTY. In addition,
Schott management board chairman Udo Ungeheuer said expanding presence in Russia is an important strategic step for the benefit of customers. ”In other words, by pursuing a consistent
The offer is intended to purchase around 13,389,410 shares and is in accordance with the rules of the Securities and Exchange Board of India. GSK’s Indian consumer products
Controlling DSIFprotein can help researchers to discover new methods for controlling inflammation, and immune responses, as well as the cell cycle processes that can lead to cancer. Activity
The companies are planning to submit Ruconest biologics license application (BLA) within the first six months of 2013 to the FDA. Upon the acceptance of BLA for FDA
The selected candidate, CAM-1, was effective against all tested MRSA along with hospital and community acquired MRSA strains than current standard antibiotics. Mode of action of the new
The lab, which was temporarily shut down for revision, has again resumed operations to serve stem cell banking customers. The GTP Centre I, which has been initially completed
Along with the Repligen’s enhanced bioprocessing products, the company also offers protein A, growth factor products for cell culture fermentation as well as OPUS pre-packed chromatography columns for
The council in its representation has also sought omission of the merchant exporters from bar coding completely as the industry is mainly made up of small scale and
Somatoprim, the somatostatin analog (SSA) based on a novel amino acid composition, demonstrated significant receptor binding and pharmacological profile compared to currently marketed SSAs. Aspireo CEO Carsten Dehning